ClearBridge Investments’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $917M | Sell |
|
|||||
|
2020
Q3 | $733M | Sell |
|
|||||
|
2020
Q2 | $774M | Buy |
|
|||||
|
2020
Q1 | $588M | Buy |
|
|||||
|
2019
Q4 | $686M | Buy |
|
|||||
|
2019
Q3 | $611M | Buy |
|
|||||
|
2019
Q2 | $787M | Buy |
|
|||||
|
2019
Q1 | $785M | Buy |
|
|||||
|
2018
Q4 | $501M | Sell |
|
|||||
|
2018
Q3 | $720M | Buy |
|
|||||
|
2018
Q2 | $557M | Buy |
|
|||||
|
2018
Q1 | $451M | Buy |
|
|||||
|
2017
Q4 | $424M | Buy |
|
|||||
|
2017
Q3 | $454M | Buy |
|
|||||
|
2017
Q2 | $373M | Buy |
|
|||||
|
2017
Q1 | $321M | Buy |
|
|||||
|
2016
Q4 | $278M | Buy |
|
|||||
|
2016
Q3 | $207M | Buy |
|
|||||
|
2016
Q2 | $163M | Buy |
|
|||||
|
2016
Q1 | $90.9M | Buy |
|
|||||
|
2015
Q4 | $16.3M | Buy |
|
|||||
|
2015
Q3 | $10.3M | Buy |
|
|||||
|
2015
Q2 | $10M | Buy |
|
|||||
|
2015
Q1 | $2.23M | Buy |
|
|||||
|
2014
Q4 | $2.21M | Buy |
|
|||||
|
2014
Q3 | $1.94M | Buy |
|
|||||
|
2014
Q2 | $1.6M | Sell |
|
|||||
|
2014
Q1 | $1.61M | Sell |
|
|||||
|
2013
Q4 | $1.9M | Buy |
|
|||||
|
2013
Q3 | $1.48M | Sell |
|
|||||
|
2013
Q2 | $1.69M | Buy |
|